Crispr Therapeutics shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.8M | 58k | 64.81 |
| 2025-06-30 | $2.9M | 59k | 48.62 |
| 2025-03-31 | $2.2M | 64k | 34.02 |
| 2024-12-31 | $2.8M | 71k | 39.35 |
| 2024-09-30 | $3.9M | 85k | 45.38 |
| 2024-06-30 | $4.0M | 74k | 53.48 |
| 2024-03-31 | $5.9M | 86k | 68.16 |
| 2023-12-31 | $6.1M | 97k | 62.60 |
| 2023-09-30 | $5.2M | 116k | 45.38 |
| 2023-06-30 | $6.7M | 119k | 56.14 |
| 2023-03-31 | $5.6M | 124k | 45.23 |
| 2022-12-31 | $5.0M | 122k | 40.64 |
| 2022-09-30 | $15M | 226k | 65.35 |
| 2022-06-30 | $16M | 264k | 60.77 |
| 2022-03-31 | $11M | 173k | 62.77 |
| 2021-12-31 | $9.9M | 131k | 75.78 |
| 2021-09-30 | $6.5M | 58k | 111.93 |
| 2021-06-30 | $9.0M | 56k | 161.88 |
| 2021-03-31 | $94k | 774 | 121.45 |
| 2020-12-31 | $130k | 850 | 152.94 |
| 2020-03-31 | $63k | 1.5k | 42.06 |